The Diverse Roles of Heme Oxygenase-1 in Tumor Progression

Heme oxygenase-1 (HO-1) is an inducible intracellular enzyme that is expressed in response to a variety of stimuli to degrade heme, which generates the biologically active catabolites carbon monoxide (CO), biliverdin and ferrous iron (Fe2+). HO-1 is expressed across a range of cancers and has been d...

Full description

Bibliographic Details
Main Authors: Kim Ngan Luu Hoang, Joanne E. Anstee, James N. Arnold
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.658315/full
_version_ 1828890281262448640
author Kim Ngan Luu Hoang
Joanne E. Anstee
James N. Arnold
author_facet Kim Ngan Luu Hoang
Joanne E. Anstee
James N. Arnold
author_sort Kim Ngan Luu Hoang
collection DOAJ
description Heme oxygenase-1 (HO-1) is an inducible intracellular enzyme that is expressed in response to a variety of stimuli to degrade heme, which generates the biologically active catabolites carbon monoxide (CO), biliverdin and ferrous iron (Fe2+). HO-1 is expressed across a range of cancers and has been demonstrated to promote tumor progression through a variety of mechanisms. HO-1 can be expressed in a variety of cells within the tumor microenvironment (TME), including both the malignant tumor cells as well as stromal cell populations such as macrophages, dendritic cells and regulatory T-cells. Intrinsically to the cell, HO-1 activity provides antioxidant, anti-apoptotic and cytoprotective effects via its catabolites as well as clearing toxic intracellular heme. However, the catabolites of heme degradation can also diffuse outside of the cell to extrinsically modulate the wider TME, influencing cellular functionality and biological processes which promote tumor progression, such as facilitating angiogenesis and metastasis, as well as promoting anti-inflammation and immune suppression. Pharmacological inhibition of HO-1 has been demonstrated to be a promising therapeutic approach to promote anti-tumor immune responses and inhibit metastasis. However, these biological functions might be context, TME and cell type-dependent as there is also conflicting reports for HO-1 activity facilitating anti-tumoral processes. This review will consider our current understanding of the role of HO-1 in cancer progression and as a therapeutic target in cancer.
first_indexed 2024-12-13T12:56:03Z
format Article
id doaj.art-ab7ce2ce6c664c9f8e4d69a2cd82df45
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-13T12:56:03Z
publishDate 2021-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-ab7ce2ce6c664c9f8e4d69a2cd82df452022-12-21T23:45:11ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-03-011210.3389/fimmu.2021.658315658315The Diverse Roles of Heme Oxygenase-1 in Tumor ProgressionKim Ngan Luu HoangJoanne E. AnsteeJames N. ArnoldHeme oxygenase-1 (HO-1) is an inducible intracellular enzyme that is expressed in response to a variety of stimuli to degrade heme, which generates the biologically active catabolites carbon monoxide (CO), biliverdin and ferrous iron (Fe2+). HO-1 is expressed across a range of cancers and has been demonstrated to promote tumor progression through a variety of mechanisms. HO-1 can be expressed in a variety of cells within the tumor microenvironment (TME), including both the malignant tumor cells as well as stromal cell populations such as macrophages, dendritic cells and regulatory T-cells. Intrinsically to the cell, HO-1 activity provides antioxidant, anti-apoptotic and cytoprotective effects via its catabolites as well as clearing toxic intracellular heme. However, the catabolites of heme degradation can also diffuse outside of the cell to extrinsically modulate the wider TME, influencing cellular functionality and biological processes which promote tumor progression, such as facilitating angiogenesis and metastasis, as well as promoting anti-inflammation and immune suppression. Pharmacological inhibition of HO-1 has been demonstrated to be a promising therapeutic approach to promote anti-tumor immune responses and inhibit metastasis. However, these biological functions might be context, TME and cell type-dependent as there is also conflicting reports for HO-1 activity facilitating anti-tumoral processes. This review will consider our current understanding of the role of HO-1 in cancer progression and as a therapeutic target in cancer.https://www.frontiersin.org/articles/10.3389/fimmu.2021.658315/fullheme oxygenase-1 (HO-1)cancercytoprotectiontumor immunologyangiogenesistumor associated macrophages (TAMs)
spellingShingle Kim Ngan Luu Hoang
Joanne E. Anstee
James N. Arnold
The Diverse Roles of Heme Oxygenase-1 in Tumor Progression
Frontiers in Immunology
heme oxygenase-1 (HO-1)
cancer
cytoprotection
tumor immunology
angiogenesis
tumor associated macrophages (TAMs)
title The Diverse Roles of Heme Oxygenase-1 in Tumor Progression
title_full The Diverse Roles of Heme Oxygenase-1 in Tumor Progression
title_fullStr The Diverse Roles of Heme Oxygenase-1 in Tumor Progression
title_full_unstemmed The Diverse Roles of Heme Oxygenase-1 in Tumor Progression
title_short The Diverse Roles of Heme Oxygenase-1 in Tumor Progression
title_sort diverse roles of heme oxygenase 1 in tumor progression
topic heme oxygenase-1 (HO-1)
cancer
cytoprotection
tumor immunology
angiogenesis
tumor associated macrophages (TAMs)
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.658315/full
work_keys_str_mv AT kimnganluuhoang thediverserolesofhemeoxygenase1intumorprogression
AT joanneeanstee thediverserolesofhemeoxygenase1intumorprogression
AT jamesnarnold thediverserolesofhemeoxygenase1intumorprogression
AT kimnganluuhoang diverserolesofhemeoxygenase1intumorprogression
AT joanneeanstee diverserolesofhemeoxygenase1intumorprogression
AT jamesnarnold diverserolesofhemeoxygenase1intumorprogression